These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3459340)

  • 1. In vitro assessment of antifungal drug resistance.
    Holmberg K
    Acta Derm Venereol Suppl (Stockh); 1986; 121():131-8. PubMed ID: 3459340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antifungal susceptibility testing in patient management.
    Forrest G
    Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
    Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
    J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro methods for antifungal susceptibility testing of Trichophyton spp.
    Barros ME; Santos Dde A; Hamdan JS
    Mycol Res; 2006 Nov; 110(Pt 11):1355-60. PubMed ID: 17070026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in antifungal susceptibility testing.
    Johnson EM
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i13-8. PubMed ID: 18063599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
    Mallátová N
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of in vitro antifungal susceptibility testing.
    Espinel-Ingroff A
    Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
    Karaca N; Koç AN
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disk diffusion susceptibility testing of dermatophytes with imidazoles.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1995 Oct; 38(4):369-74. PubMed ID: 9726146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibility testing.
    Fothergill AW; Rinaldi MG; Sutton DA
    Infect Dis Clin North Am; 2006 Sep; 20(3):699-709. PubMed ID: 16984876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies in the treatment of systemic fungal infections.
    Medoff G; Kobayashi GS
    N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703
    [No Abstract]   [Full Text] [Related]  

  • 19. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
    Otcenásek M; Buchta V
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.